Floatz logo

Ibuprofen

Chronic Pain Syndrome

Aga Khan UniversitySmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
73/ 100

Competitive context

90 Active assets in the Chronic Pain Syndrome cohort.

Asset / SponsorPhaseRating
(±)-Tramadol
EMS
Phase 4BBB
Lidocaine
National and Kapodistrian University of Athens
Phase 4BBB
METHADONE
Cari Health Inc.
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Stanford University
Phase 4BBB
NEPENTHE
Bursa City Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Ibuprofen is also rated in:

migraine disorderActive
BBB
Indicative · Phase 4
72 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative · Phase 4
68 / 100
View asset →
ibuprofen intoxication, non-human animalActive
BB
Indicative · Phase 4
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →